Evaluation of 4, 672 routine prostate biopsies performed in six African countries

Journal Africain du Cancer

Volumn 5, Issue 3, 2013, Pages 144-154

  Jalloh, M ^a   Friebel, T M ^b   Sira Thiam, F ^c   Niang, L ^a   Sy, C ^c   Siby, T ^d   Fernandez, P ^e   Mapulanga, V ^e   Maina, S ^e   Doodu Mante, S ^f   Yeboah, E ^g,h   Kyei, M ^h   Ankomah, R ⁱ   Amegbor, J ^f   Adusei, B ^f   Yegbe, P ^f   Watya, S ^j   Kaggwa, S ^j   Haiman, C ^k   Henderson, B E ^k   Narashimhamurthy, M ^l   Abuidris, D ^m   Mohamadani, A A ^m   Mohamed, E ^m   Mansoor, M O ^m   Elgaili, E M ^m   Elballal, A ^m   Zeigler Johnson, C M ^b   Heyns, C F ^e   Gueye, S M ^a   Rebbeck, T R ^b   more..

^a Hopital General de Grand Yoff   (Senegal)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Centre de Diagnostic et de Recherche en Médecine Moléculaire   (Senegal)

^d Laboratoire Bio24   (Senegal)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f University of Ghana Medical School ^*  (Ghana)

^g NyahoHospital   (Ghana)

^h KORLE BU TEACHING HOSPITAL   (Ghana)

ⁱ UNIVERSITY OF GHANA   (Ghana)

^j MAKERERE UNIVERSITY   (Uganda)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l Bokamoso Private Hospital   (Botswana)

^m UNIVERSITY OF GEZIRA   (Sudan)

more..

Author keywords

Africa; Biopsy; Prostate cancer; Tumor characteristics

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; BOTSWANA; CONTROLLED STUDY; EUROPEAN AMERICAN; GHANA; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; RACE DIFFERENCE; REVIEW; SENEGAL; SOUTH AFRICA; SUDAN; UGANDA; VERY ELDERLY; WHITE SOUTH AFRICAN;

EID: 84892819276     PISSN: 19650817     EISSN: 19650825     Source Type: Journal    
DOI: 10.1007/s12558-013-0264-y     Document Type: Review

References (17)

1. SEER Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute
2. Jemal A, Center MM, De Santis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893-1907
3. Potosky AL, Miller BA, Albertsen PC, et al (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548-52
4. Odedina FT, Akinremi TO, Chinegwundoh F, et al (2009) Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 4 Suppl 1:S2
5. Ferlay J, Shin HR, Bray F, et al (2008) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-917
6. Gueye SM, Zeigler-Johnson CM, Friebel T, et al (2003) Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology 61:987-92
7. Ouzaid I, Xylinas E, Campeggi A, et al (2011) Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6-and 12-core biopsy and diagnosed with a 21-core biopsy protocol. World J Urol Epub
8. Auprich M, Augustin H, Budaus L, et al (2011) A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy. BJU Int Epub
9. Niang L, Kouka CN, Jalloh M, et al (2011) Screening for prostate cancer by digital rectal examination and PSA determination in Senegal. ISRN Oncol 2011:943704
10. Nwosu V, Carpten J, Trent JM, et al (2001) Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet 10(20):2313-8
11. Berney DM, Montironi R, Egevard L (2011) Pathology in prostate research: optimizing the pathological data. Acta Oncol 50 Suppl 1:49-52
12. Heidenreich A, Bellmunt J, Bolla M, et al (2011) EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease. Actas Urol Esp 35:501-14
13. Cohen MS, Hanley RS, Kurteva T, et al (2008) Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol 54(2):371-81
14. Pashayan N, Pharoah P, Neal DE, et al (2009) Stage shift in PSAdetected prostate cancers-effect modification by Gleason score. J Med Screen 16(2):98-101
15. Stark JR, Perner S, Stampfer MJ, et al (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27 (21):3459-64
16. Delgado-Cruzata L, Hruby GW, Gonzalez K, et al (2012) DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer. DNA Cell Biol 31(2):187-92
17. Ou Y, Shen D, Zeng J, et al (2009) Sampling the spatial patterns of cancer: optimized biopsy procedures for estimating prostate cancer volume and Gleason Score. Med Image Anal 13(4):609-20